美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=ACTONEL
符合检索条件的记录共6
1 页 当前第 1 页  返回检索页
1药品名称ACTONEL
申请号020835产品号001
活性成分RISEDRONATE SODIUM市场状态处方药
剂型或给药途径TABLET;ORAL规格30MG
治疗等效代码AB参比药物
批准日期1998/03/27申请机构ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD
2药品名称ACTONEL
申请号020835产品号002
活性成分RISEDRONATE SODIUM市场状态处方药
剂型或给药途径TABLET;ORAL规格5MG
治疗等效代码AB参比药物
批准日期2000/04/14申请机构ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD
3药品名称ACTONEL
申请号020835产品号003
活性成分RISEDRONATE SODIUM市场状态处方药
剂型或给药途径TABLET;ORAL规格35MG
治疗等效代码AB参比药物
批准日期2002/05/25申请机构ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD
4药品名称ACTONEL
申请号020835产品号004
活性成分RISEDRONATE SODIUM市场状态停止上市
剂型或给药途径TABLET;ORAL规格75MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2007/04/16申请机构ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD
5药品名称ACTONEL
申请号020835产品号005
活性成分RISEDRONATE SODIUM市场状态处方药
剂型或给药途径TABLET;ORAL规格150MG
治疗等效代码AB参比药物
批准日期2008/04/22申请机构ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD
6药品名称ACTONEL WITH CALCIUM (COPACKAGED)
申请号021823产品号001
活性成分CALCIUM CARBONATE; RISEDRONATE SODIUM市场状态停止上市
剂型或给药途径TABLET, TABLET;ORAL规格EQ 500MG BASE,N/A;N/A,35MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2005/08/12申请机构WARNER CHILCOTT CO LLC